Specialty Pharma Journal Specialty, Precision & Technology
If you are a media professional with a question about Specialty, Precision & Technology Pharma Journal, or would like to inquire about submitting advertisements, please submit your request using the form below. We will do our best to respond before your deadline.
Breaking News
- FDA Approves ViiV Healthcare’s Rukobia, a First-in-Class Treatment for HIV in Adults with Few Treatment Options
- Phase 3 Trial of Kevzara in COVID-19 Patients Requiring Mechanical Ventilation Fails to Meet Primary and Secondary Endpoints
- CENTOGENE Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test
- MEI Pharma and Helsinn Group Discontinue Phase 3 Study of Pracinostat in AML After Interim Analysis
- Alexion Completes Acquisition of Portola Pharmaceuticals
- Sarepta Therapeutics Signs Agreement with Hansa Biopharma for Imlifidase as a Pre-Treatment Ahead of Gene Therapy in Select Indications
- Ipsen Joins Collaboration to Evaluate Cabozantinib Plus Atezolizumab in Metastatic NSCLC and Metastatic Castration-Resistant Prostate Cancer
- FDA Grants Fast Track Designation to MetVital’s Anhydrous Enol-Oxaloacetate for Glioblastoma Multiforme
- Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2
- FDA Approves Bavencio as First-Line Maintenance Treatment for Locally Advanced or Metastatic Urothelial Carcinoma